Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q2 2026)
11,207,000
Value
$248.9M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of DYN by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,207,000$248.9M<0.1%+2,298,020+25.8%AddedHolders
Q1 20268,908,980$161.5M<0.1%+2,339,059+35.6%AddedHolders
Q4 20256,569,921$128.5M<0.1%+1,168,005+21.6%AddedHolders
Q3 20255,401,916$68.3M<0.1%+108,547+2.1%AddedHolders
Q2 20255,293,369$50.4M<0.1%+98,075+1.9%AddedHolders
Q1 20255,195,294$54.3M<0.1%−2,801,637−35.0%ReducedHolders
Q4 20247,996,931$188.4M<0.1%−1,029,766−11.4%ReducedHolders
Q3 20249,026,697$324.2M<0.1%+3,707,734+69.7%AddedHolders
Q2 20245,318,963$187.7M<0.1%+2,100,570+65.3%AddedHolders
Q1 20243,218,393$91.4M<0.1%+1,935,581+150.9%AddedHolders
Q4 20231,282,812$17.1M<0.1%+436,452+51.6%AddedHolders
Q3 2023846,360$7.58M<0.1%−52,932−5.9%ReducedHolders
Q2 2023899,292$10.1M<0.1%+490,236+119.8%AddedHolders
Q1 2023409,056$4.71M<0.1%−165,064−28.8%ReducedHolders
Q4 2022574,120$6.65M<0.1%+500,878+683.9%AddedHolders
Q3 202273,242$930.0K<0.1%+409+0.6%AddedHolders
Q2 202272,833$500.0K<0.1%+66+0.1%AddedHolders
Q1 202272,767$701.0K<0.1%+55,567+323.1%AddedHolders
Q4 202117,200$205.0K<0.1%+17,200NewHolders
Q2 20210$00.0%−211,483−100.0%Sold outHolders
Q1 2021211,483$3.28M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.